Background: Complex hemostatic mechanisms are involved in the pathophysiology of
various diseases, including cardiovascular diseases. Among them, dysregulation of platelet …

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for their analgesic,
antipyretic, and antiinflammatory properties, and aspirin is increasingly employed in the …

Venous thromboembolism (VTE; deep vein thrombosis and/or pulmonary embolism) is a
well-established cause of morbidity and mortality in the medical and surgical patient …

OBJECTIVES: We evaluated the effect of the use of aspirin, nonsteroidal anti-inflammatory
drugs (NSAIDS), and anticoagulants on the performance of immunochemical fecal occult …

Platelets are the main effectors of the thrombotic events occurring at a ruptured
atherosclerotic plaque and therefore antiplatelet agents are the mainstay of antithrombotic …

Aspirin is a widely used medication and has become a cornerstone for treating
cardiovascular disease. Aspirin can significantly reduce the incidence of cardiovascular …

Platelets are key mediators in the pathophysiology of atherothrombotic disease.
Inappropriate platelet activation can lead to thrombosis and ischemic events. Platelet …

Background: Although most epidemiological studies suggest that non-steroidal anti-
inflammatory drug use is inversely associated with prostate cancer risk, the magnitude and …

In the setting of ST-segment elevation myocardial infarction (STEMI), patients at high risk of
systemic emboli who undergo primary percutaneous coronary intervention (PCI) using …

This article reviews gender-specific differences in platelet function and response to aspirin.
In contrast with men, women under 65 years of age do not benefit from aspirin therapy in …